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Background: The human papillomavirus (HPV) genomes can replicate, and are maintained as autonomously
replicating extrachromosomal plasmids in human U2OS cells. Previous studies have shown that HPV genomes
are transcriptionally active in U2OS cells and can express the viral early proteins required for initiation and
establishment of HPV replication. In the present work, we have examined the involvement of cellular DAXX
protein in HPV replication in U2OS cells.
Methods: We have used indirect immunofluorescence and FISH analysis in order to study HPV replication
compartments in U2OS cells. In addition, we have used siRNA knock-down for examining the effect of the
DAXX protein on HPV replication and transcription in U2OS cells.
Results: We show that a portion of HPV replication foci are partially co-localized with components of ND10,
cellular DAXX and PML proteins. In addition, we demonstrate that the knock-down of the cellular DAXX protein
modulates the HPV genome replication and transcription in U2OS cells – papillomavirus replication is reduced
in the absence of this component of ND10.
Conclusions: The DAXX protein modulates the early gene expression and the transient replication of HPV
genomes in U2OS cells.
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Papillomaviruses are small, double-stranded DNA viruses
which infect the epithelial tissue of a wide variety of verte-
brates and induce proliferative lesions of the skin and
mucosa. The human papillomavirus (HPV) high-risk types,
such as HPV16, 18 and 31, are associated with anogenital
cancer, and are the primary aetiological agents for cervical
carcinoma. Low-risk types, for instance HPV6 or 11,
can cause genital warts [1]. Papillomaviruses establish
long-term persistent infection in stratified squamous
epithelium. The viral life cycle is tightly linked to the
differentiation status of the host cells. After infection of
the basal cells of the epithelium, the viral genome is
replicated until an optimal copy number is reached.
This is called the initial amplification, or establishment* Correspondence: reet.kurg@ut.ee
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creativecommons.org/publicdomain/zero/1.0/phase, of PV replication. It is followed by a maintenance
phase, during which a constant copy number of extrachro-
mosomal viral genomes is maintained in the nuclei of host
cells as they divide. The viral E1 and E2 proteins, together
with the host cell replication machinery, are responsible
for HPV DNA replication at both early stages of virus
replication [reviewed in [2].
Many DNA viruses replicate their genomes in close
proximity to ND10. It has been suggested that ND10 is
important for antiviral defense and is a part of the intrinsic
immune system [3]. Swindle and others have demonstrated
that HPV11 replication compartments partially overlap
with PML in C33A cells [4]. However, the functional
role of ND10 in papillomavirus infection is still contro-
versial. In the case of BPV1, ND10 seems to positively
affect papillomavirus infectivity as the presence of PML
and intact ND10 are associated with enhanced BPV1
early gene expression [5]. Yet others have shown thatarticle distributed under the terms of the Creative Commons Attribution License
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tion in transfected cells [6]. More recent data show that
ND10 proteins have opposing roles in viral transcription;
SP100 knock-down enhances HPV18 early transcription
in primary human keratinocytes, while PML and DAXX
knock-down decreases it [7].
One component of the ND10 is the DAXX protein,
which is a highly conserved nuclear protein involved in
regulation of apoptosis and gene expression [8]. It is pre-
dominantly located in the cell nucleus, where it is associ-
ated with two nuclear domains: the ND10 and condensed
heterochromatin [9]. In transcription regulation, the DAXX
protein functions mainly as a co-repressor. It associates
with histone deacetylases (HDACs), DNA methyltrans-
ferases (DNMTs), core histones, DEK, ATRX and other
chromatin-associated factors [10–13], suggesting that it
represses transcription through modification of chromatin.
The repressive function of DAXX has been associated
with cellular intrinsic immune response against incoming
viruses. Through the action of HDACs, DAXX silences
immediate-early (IE) gene expression of human cyto-
megalovirus (HCMV) by inducing a transcriptionally
inactive chromatin state around the major IE promoter
[3, 14, 15]. The DAXX protein is also involved in negative
regulation of adenovirus (Ad5) replication [16], and ini-
tiation and maintenance of retroviral silencing, which is
facilitated by HDACs and DNMTs recruitment to retroviral
(ASV-1, HIV-1) DNA [13, 17, 18].
Most established human cell lines fail to support HPV
genome replication. However, both alphapapillomaviruses,
including HPV11 and 18, and betapapillomaviruses are able
to replicate extrachromosomally and establish a stable
replication in the human osteosarcoma cell line U2OS
[19]. U2OS cells are not the natural host cells of papil-
lomaviruses, but these cells appear to contain all the
necessary cellular factors required for the replication of
papillomavirus genomes, and therefore provide a cost-
effective system for studying the fundamental processes
of papillomavirus replication. In our present work, we
have examined the HPV replication foci in U2OS cells
in relation to ND10, and the effect of one component
of ND10, the DAXX protein, on HPV genome replication
and transcription. We show that the DAXX protein modu-
lates the early gene expression and the transient replication
of HPV genomes in these cells.
Results
HPV replication foci in U2OS cells
The replication of HPV genomes occurs within the dis-
tinct replication compartments in the nuclei of U2OS
cells [19]. Both E1 and E2 proteins are required for the
initiation of HPV replication within the cells [20] and
are shown to localize in the HPV replication centers
[21]. In this study, we have used the mouse monoclonalantibodies against HPV11 E2 and rabbit polyclonal anti-
bodies against HPV18 E1 in order to characterize the
HPV replication foci in U2OS cells by indirect immuno-
fluorescence analysis. These antibodies allow us to detect
the corresponding HPV proteins expressed by the HPV
minicircle genomes.
First, we analyzed the involvement of cellular BRD4 pro-
tein in HPV replication in U2OS cells. BRD4 localizes to,
and is essential for the formation of HPV replication foci in
primary human foreskin keratinocytes. However, when E1
and E2 begin to amplify the viral DNA, BRD4 is displaced
from the foci [21]. In order to test whether this is also the
case in U2OS cells, we performed an immunofluorescence
assay. Six days after transfection with 2 μg of wt HPV11
minicircle genomes, the cells were fixed and immuno-
stained for HPV11 E2 and BRD4 proteins. As shown in
Fig. 1, the individual U2OS cells contained different
number of HPV11 E2 foci (Fig. 1 HPV11 E2 column).
We detected up to ten HPV11 E2 foci, with an average
value of four foci per cell nucleus. The HPV replication
foci also had a different size. The small HPV11 E2 foci
co-localized with the cellular BRD4 protein (Fig. 1a),
and were reminiscent of the small early HPV replica-
tion foci that were described in human keratinocytes by
Sakakibara and others [21]. Large HPV11 E2 foci were
also visible in U2OS cells at the same time-point, and the
cellular BRD4 protein was absent from these foci (Fig. 1b).
Overall, this indicates the involvement of BRD4 in the early
steps of replication foci formation in U2OS cells, similar to
what has been observed in human keratinocytes [21].
HPV replication foci localization in relation to ND10 in
U2OS cells
The main aim of this work was to analyze the localization
of HPV replication centers in relation to components of
ND10 in U2OS cells. Many DNA viruses replicate their ge-
nomes in close proximity to ND10, and several reports link
multiple stages of HPV infection with these nuclear sites [4,
5, 22, 23]. However, the role of ND10 in papillomavirus in-
fection is still controversial. In order to analyze the link be-
tween HPV replication and ND10 in U2OS cells, we first
analyzed the localization of the HPV E2 protein and cellular
DAXX protein, a constitutive component of ND10. For this
purpose, U2OS cells were transfected with 2 μg of wt
HPV11 minicircle genomes, fixed six days later and immu-
nostained for HPV11 E2 and cellular DAXX proteins. On
average, seven DAXX-containing foci per cell nucleus were
observed (Fig. 2 DAXX column), and 34 % of the E2 foci
overlapped partially with DAXX-containing foci. Represen-
tative images of cells with different number and size of
HPV11 E2 foci and DAXX staining are shown in Fig. 2a
and b. A similar analysis with HPV18 replication centers
failed due to the fact that we were unable to find mouse
monoclonal antibodies against the DAXX protein suitable
Fig. 1 HPV replication foci in U2OS cells. Immunofluorescence analysis of U2OS cells transfected with HPV11 genome. U2OS cells were transfected
with wt HPV11 minicircle genomes and grown on coverslips. Six days after transfection cells were fixed and immunostained with antibodies for HPV11
E2 (green) and BRD4 (red). Cell nuclei were detected by DAPI. Analysis was carried out at least three times starting from cell transfections. a and b
represent cells with different number and size of HPV11 E2 foci. On the right panels, the intensity profiles are shown
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immunofluorescence analysis coupled with FISH detection
of HPV18 DNA. U2OS cells were transfected with 5 μg of
wt HPV18 minicircle genomes and fixed six days later. The
cells were immunostained for DAXX protein and HPV
DNA was detected with an HPV18 specific probe (Fig. 2c).
We observed at least partial co-localization of DAXX and
HPV DNA in 22 % of the HPV18 DNA foci in U2OS cells.
In order to confirm the partial co-localization of HPV
replication centers and ND10, immunofluorescence ana-
lysis was performed with another component of ND10,
the PML protein. First U2OS cells were transfected with
2 μg of wt HPV11 minicircle genomes and immuno-
stained for HPV11 E2 and cellular PML proteins. The
PML signal was observed in a punctate pattern in the
cell nucleus, with an average of 14 PML structures per
nucleus (Fig. 3a, b; PML column). 44 % of the E2 foci
overlapped partially with PML-containing foci. In many
cases, HPV replication foci and ND10 localized side by
side. Representative images of cells with different num-
ber and size of HPV11 E2 foci and PML staining are
shown in Fig. 3a and b. A similar analysis was performed
with HPV18; however, in this case the immunofluores-
cence analysis was carried out with HPV18E8- genome.
The HPV18E8- mutant replicates at a higher level than
the wt HPV18 genome [24, 25], resulting in a higher and
more easily detectable HPV18 E1 protein level in the
transfected cells. In the case of the HPV18E8- genome,we detected up to 24 E1 foci per cell nucleus, with an
average of 10 foci per cell. Examples of typical cells with
different sizes of E1 foci are shown in Fig. 3c, d, e and f.
42 % of the E1 foci overlapped, at least partially, with
PML signal in U2OS cells six days after transfection.
However, in most of the cells, there was no perfect co-
localization of HPV18 E1 protein and PML signals; rather,
a portion of the E1 foci overlapped with PML partially. In
a few cells, we were able to detect very small E1 foci sur-
rounded by the PML protein, as shown in Fig. 3c.
In summary, our immunofluorescence analyses indi-
cate that a fraction of HPV replication foci localize in
proximity of components of ND10, the DAXX and PML
proteins in U2OS cells.
DAXX modulates the transient replication of HPV
genomes in U2OS cells
In order to analyze the involvement of the DAXX protein
in HPV genome replication in U2OS cells, we knocked
down the expression of DAXX with siRNA and trans-
fected the cells with wt HPV11 and wt HPV18 genomic
DNA. Episomal DNA was isolated 72 h after transfection,
and the newly replicated HPV11 and HPV18 viral DNA
was analyzed by Southern blot (Fig 4a and b). Down-
regulation of DAXX repressed the initial replication of
both HPV11 and HPV18 genomes. We also analyzed the
HPV DNA levels by quantitative real-time PCR, using
mitochondrial DNA as an internal control. Consistent
Fig. 2 The localization of HPV replication foci in U2OS cells in relation to the DAXX protein. a and b Immunofluorescence analysis of U2OS cells
transfected with HPV11 genome. U2OS cells were transfected with wt HPV11 minicircle genomes and grown on coverslips. Six days after transfection
cells were fixed and immunostained with antibodies for HPV11 E2 (green) and DAXX (red) proteins. Cell nuclei were detected by DAPI. Analysis was
carried out at least three times starting from cell transfections. a and b represent cells with different number and size of HPV11 E2 foci. c FISH analysis
of U2OS cells transfected with HPV18 genome. U2OS cells were transfected with wt HPV18 minicircle genomes and grown on microscope slides. Six
days after transfection cells were fixed and combined immunofluorescence and FISH analysis was performed. DAXX signal is visible in red and HPV18
DNA in green. Cell nuclei were detected by DAPI. Analysis was carried out at least three times starting from cell transfections. On the right panels, the
intensity profiles are shown
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tion products by real-time PCR indicated that down-
regulation of the DAXX protein reduced HPV DNA
replication by 2-3-fold (Fig. 4c). The level of DAXX
protein in U2OS cells treated with siDaxx or siCtr is
shown in Fig. 4d.DAXX modulates HPV early gene expression in U2OS cells
The HPV genomes are transcriptionally active in U2OS
cells and express all the viral early proteins required for
initiation and establishment of HPV replication [19, 26].
In order to determine whether the DAXX protein is in-
volved in papillomavirus early promoter regulation, westudied the expression of viral early genes that were
transcribed from wt HPV18 and wt HPV11 episomes in
U2OS cells. Four different primer pairs were used to
measure the activity of HPV early promoters. E6, E7,
E1 and E2 primers target the corresponding coding se-
quences in the viral genome (Fig. 5d). Most of these
primers target multiple HPV transcripts in U2OS cells
[26]. HPV18 E6 primers detect six differently spliced
transcripts from early promoter P102; HPV18 E7 primers
detect the same six transcripts, along with an additional
three transcripts from promoter P520. HPV18 E1 primers
detect a single E1 encoding transcript originating from
promoter P102, and HPV18 E2 primers detect transcripts
from three different promoters (P102, P811 and P1193).
Fig. 3 The localization of HPV replication foci in U2OS cells in relation to the PML protein. Immunofluorescene analysis of U2OS cells transfected
with HPV11 and HPV18E8- genomes. a and b U2OS cells were transfected with wt HPV11 minicircle genomes and grown on coverslips. Six days
after transfection cells were fixed and immunostained with antibodies for HPV11 E2 (green) and PML (red) proteins. Cell nuclei were detected by
DAPI. Analysis was carried out at least three times starting from cell transfections. a and b represent cells with different number and size of
HPV11 E2 foci. c, d, e and f U2OS cells were transfected with HPV18E8- minicircle genomes and grown on coverslips. Six days after transfection
cells were fixed and immunostained with antibodies for HPV18 E1 (green) and PML (red) proteins. Cell nuclei were detected by DAPI. Analysis
was carried out at least three times starting from cell transfections. c, d, e and f represent cells with different number and size of HPV18 E1 foci.
On the right panels, the intensity profiles are shown
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Fig. 4 Down-regulation of DAXX represses HPV genome transient replication. U2OS cells were first transfected with Daxx siRNA or a control siRNA, and
24 h later with wt HPV18 (a) or wt HPV11 (b) genome. Cells were harvested 72 h after transfection, episomal DNA was isolated, digested with DpnI and
linearizing enzyme, EcoRI or BamHI, and analyzed by Southern blotting using a radiolabeled probe specific for the viral genome. The linearizing enzyme
(M1) and DpnI (M2) digested pBRHPV18 or pUCHPV11 plasmids as markers are shown on the right. c qPCR analysis of the episomal DNA
isolated in replication assays. Episomal DNA was digested with DpnI and analysed by qPCR using HPV18 or HPV11 genome, and mitochondrial DNA
specific primers. The data represent the average of three independent experiments and are presented graphically relative to the basal replication level
of the HPV18 or HPV11 genome. d Western blot analysis of the DAXX protein levels in the cells used in replication assays. Cells (105) were lysed,
separated electrophoretically, and immunoblotted with anti-DAXX and anti-tubulin antibodies
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HPV11 genome.
U2OS cells were first transfected with siCtr or siDaxx,
and twenty-four hours later, the cells were electroporated
with 2 μg of either wt HPV11 or 18 DNA. After an add-
itional 48 hours, RNA was extracted and the HPV tran-
script levels were analyzed. In order to compare the level
of viral early promoters of HPV18 and HPV11 genomes,
the viral transcript signals were expressed relative to cellu-
lar HPRT1 mRNA level. The HPV11 early promoters were
more active when compared to HPV18 in U2OS cells,
which is consistent with the replication efficiency of HPV
11 and 18 genomes in U2OS cells (Fig. 4). siDaxx treat-
ment of U2OS cells prior to transfection with HPV18
DNA decreased the viral early gene expression by approxi-
mately 2-fold (Fig. 5a and c). Similar results were obtained
with the HPV11 genome (Fig. 5a). The knock-down of
DAXX did not influence the expression level of cellular
housekeeping gene beta-actin (Fig. 5b). In summary, our
data indicate that DAXX knock-down leads to a reduction
in virus early gene expression.
Discussion
In this study, we have examined the HPV replication foci in
relation to cellular ND10 in U2OS cells. HPV replicationfoci, containing the viral genome, virus early proteins
required for initiation of the replication, and cellular
components ensuring the efficient propagation of the
virus, are formed at specific sites in the nucleus. Our
results indicate that a portion of HPV replication centers
co-localize partially with components of the ND10, the
DAXX and PML proteins. This is consistent with the work
of Swindle et al. [4], who have previously shown that in
C33A cells transfected with HPV11 viral ori sequence
and E1 and E2 expression vectors, the viral proteins co-
localize, at least partially, with PML in a portion of the
cells. In addition, Rivera-Molina and others have demon-
strated that HPV11 DNA/E2 protein complex recruits
ND10 proteins, HPV DNA/protein complex co-localized
with DAXX independently of PML, and with PML inde-
pendently of the DAXX protein [27]. These data confirm
that papillomavirus genomes replicate in close proximity
to ND10.
Several other DNA viruses (herpes simplex virus type
1, simian virus 40, human adenovirus type 5) replicate
and transcribe predominantly at close proximity to ND10
[28]. These similarities might originate from the require-
ment to control common cellular factors that participate in
viral genome replication or transcription. Components of
ND10 are interferon inducible transcriptional repressors,
Fig. 5 Down-regulation of DAXX represses HPV early gene expression. U2OS cells were first transfected with Daxx siRNA or a control siRNA, and
24 h later with wt HPV18 or wt HPV11 genome. 48 h after transfection total RNA was isolated, reverse transcribed and analyzed by qPCR. Each
sample was analyzed in triplicate with E6, E7, E1, E2, beta-actin and HPRT1 specific primers. HPV11 and 18 (a) and bACT (b) mRNA levels were
calculated relative to HPRT1 mRNA levels. The data represent the average of three independent experiments. Blow-out of HPV18 part from (a) is
shown in (c). d The location of four different primer pairs targeted against HPV E6, E7, E1 and E2 coding sequences in HPV18 early region
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against viruses. As a result, most DNA viruses have devel-
oped mechanisms to antagonize the restrictive function
of ND10 [29]. In the case of papillomaviruses, however,
the interaction with ND10 is controversial. The DAXX
protein appears to have a positive role in HPV transcription
and regulation. Our results show that knock-down of one
component of ND10, the cellular DAXX protein, leads to
reduced HPV11 and HPV18 early transcription and viral
replication in U2OS cells. This result is consistent with a
more detailed study by Stepp and others [7] of the roles of
three components of ND10 in the early stages of HPV18
infection in primary human keratinocytes; PML, SP100 and
DAXX. They revealed that PML and DAXX knock-down
leads to a reduction in HPV18 transcription, while SP100
behaves as a repressor of viral infection. The presence of
PML and intact ND10 is also associated with enhanced
BPV1 early gene expression [5].Recent work from different groups has demonstrated
that HPV infection triggers the host cell DNA damage
response (DDR) by activating the ATM-Chk2-dependent
pathway [25, 30–32]. Activation of ATM is necessary for
efficient, productive amplification of HPV [33]. Many of
the DDR proteins that co-localize with HPV replication
compartments also associate with PML and have the po-
tential to reside in ND10 and, along with PML, relocate
to sites of DNA damage (reviewed in [34]). The ND10
may therefore form a depot of cellular proteins that are
involved in viral replication or transcription, and this
could explain why the cellular environment around
ND10 could be particularly advantageous for the papillo-
mavirus during certain stages of the viral life cycle. The
ND10 can act as DNA damage sensors that go through
structural changes, increasing in their numbers in re-
sponse to DNA damage [35]. Indeed, it has been shown
that within the poorly differentiated basal and parabasal
Kivipõld et al. Virology Journal  (2015) 12:104 Page 8 of 10layers of the stratified epithelia, where the early stage of
the viral life cycle takes place, the number of ND10 is in-
creased in the presence of HPV genomes [6].
While the replication of HPV origin-containing plasmids
can be reconstituted in many cell types by expressing viral
replication proteins E1 and E2 from heterologous plasmids,
most of the established human cell lines fail to support
HPV genome replication [36]. Papillomaviruses have
the capacity to establish long-term persistent infection
in U2OS cells. This is achieved through the interplay
between viral and cellular factors involved in virus gene
expression and genome replication. We have shown that,
similar to human keratinocytes, in U2OS cells the BRD4
protein is localized in HPV replication foci in the begin-
ning of replication and is displaced when the foci increase
in size. HPV replication centers in U2OS cells contain
markers of homologous recombination similar to HPV31
foci in human keratinocytes [25, 32, 33]. All these data
suggest that the HPV replication and cellular mechanism
triggered by it, is similar both in human keratinocytes and
in a model cell line U2OS.
Conclusions
The analysis of HPV replication foci in U2OS cells indi-
cated that HPV replication compartments overlap partially
with the DAXX and PML proteins and the early replication
is modulated by the DAXX protein. This further confirms
that HPV replication has many common features in U2OS
cells and primary human keratinocytes, suggesting that
U2OS cell line is suitable for studying the basic mecha-
nisms of papillomavirus replication.
Materials and methods
siRNAs
The siRNA target sequence for human Daxx (5′-GGA
GUUGGAUCUCUCAGAA) has been published previously
[37]. As a control siRNA (siCtr), non-specific siRNA
(5’ CCCUGUCAGUAUUGAUAGAAA) was used. Both
siRNAs were purchased from Sigma-Aldrich.
Cell lines and transfections
U2OS cells obtained from the American Type Culture
Collection (ATCC) (number HTB-96) were cultured in
Iscove’s modified Dulbecco’s medium supplemented with
10 % of fetal calf serum. The transfections were carried
out either by electroporation as described in [38], applying
180 V or by lipofection using LipofectamineTM RNAiMAX
as a transfection reagent according to manufacturer’s
protocol (Invitrogen).
Replication assay
For transfection, the pBRHPV18 and pUCHPV11 plasmids
[19, 30] were digested with EcoRI and BamHI to release
the wt HPV18 and wt HPV11 genome, respectively; lineargenomes were gel-purified, re-ligated and concentrated by
ethanol precipitation [30]. 4 × 105 of U2OS cells were
seeded onto 60 mm dishes the day before transfection with
200 pmol of siDaxx and siCtr siRNA duplexes by Lipofecta-
mineTM RNAiMAX. Transfected U2OS cells were counted
24 h post-transfection and an even count of cells was trans-
fected by electroporation with 2 μg of circularized HPV18
or HPV11 genome and incubated for another 72 h. The
cells were collected, counted and low molecular weight
DNA was isolated from an even amount of cells. 4/5th of
the recovered DNA was cut with DpnI, which digests only
unreplicated DNA, and a linearizing enzyme (EcoRI or
BamHI) and analyzed by Southern blot analysis as de-
scribed in [20]. 1/65th of the remaining DNA was subjected
to qPCR analysis – DNA isolated from U2OS cells was cut
with DpnI. The primers chosen for qPCR analysis con-
tained a DpnI site in the amplified region so that only newly
synthesized DNA was analyzed.
mRNA analysis
2.5 × 105 of U2OS cells were seeded onto 60 mm dishes
the day before transfection with 200 pmol of siDaxx and
siCtr siRNA duplexes by LipofectamineTM RNAiMAX.
U2OS cells were counted 24 h post-transfection and an
even count of cells was transfected by electroporation
with 2 μg of circularized wt HPV18 or wt HPV11 gen-
ome and incubated for another 48 h. RNA was isolated
using TRIZol® reagent (Invitrogen) according to the di-
rections of the manufacturer. 5 μg of DNase I-treated
total cellular RNA was used in reverse transcription re-
actions with oligo(dT)18 primers using First Strand
cDNA Synthesis Kit (Fermentas). The reaction products
were treated with RNase H (Fermentas). 1/40th of the
cDNA was used for analysis by qPCR.
qPCR
Quantitative real-time PCR was performed using HOT
FIREPol® EvaGreen® qPCR Mix (Solis BioDyne). All sam-
ples were analyzed in triplicate and the target sequences































For immunoblotting analysis, the cells were washed twice
with PBS, detached with PBS-EDTA and lysed with SDS
loading buffer. Material from equal number of cells was
loaded on each lane, proteins were separated by SDS-
polyacrylamide gel electrophoresis and transferred by a
semi-dry blotting method to a polyvinylidene difluoride
membrane (Millipore Corp). Membranes were incubated
with rabbit anti-Daxx antibody (1:8,000; Sigma-Aldrich)
and mouse monoclonal anti-tubulin antibody (1:20,000;
Sigma-Aldrich); unconjugated primary antibodies were
visualized with secondary anti-mouse and anti-rabbit
IgG antibodies conjugated with horseradish peroxidase
(1:10,000; Icosagen). Chemoluminescent signal was de-
tected using ECL kit from Amersham Biosciences.
Immunofluorescence analysis
HPV minicircle genomes were used in immunofluores-
cence analysis. The construction and production of minicir-
cle HPV genomes has been described in [39]. U2OS cells
were electroporated with 2 μg of wt HPV11 or HPV18E8-
minicircle viral genomes and grown on microscope slides.
6 days after electroporation cells were fixed with 4 % para-
formaldehyde for 10 min and IF analysis was performed as
described in Reinson et al. [25]. IF was performed with the
following primary antibodies using indicated dilutions:
DAXX (D7810; Sigma-Aldrich) 1:100; PML (sc-966; Santa
Cruz Biotechnology) 1:100; PML (sc-5621; Santa Cruz Bio-
technology) 1:50; rabbit polyclonal antibodies BRD4B and
BRD4C [40] at final concentration 10 ng/μl; HPV11 E2
(ab100968, Abcam) at final concentration 20 ng/μl; and
rabbit polyclonal antibody HPV18 E1 [25] at final concen-
tration 20 ng/μl. Secondary antibodies Alexa Fluor® 568
Goat Anti-Rabbit IgG (A-11011); Alexa Fluor® 568 Goat
Anti-Mouse (A-11004); Alexa Fluor® 488 Goat Anti-Rabbit
IgG (A-11008); and Alexa Fluor® 488 Goat Anti-Mouse (A-
10680) were used at a dilution 1:1000 and were purchasedfrom Invitrogen. Cells were placed under coverslips with
SlowFade® Gold antifade reagent with DAPI (Invitrogen)
and analysis was performed with Zeiss confocal microscope
LSM710 using 63x oil-immersion objective.
IF-FISH analysis
U2OS cells were electroporated with 5 μg of wt HPV18
minicircle viral genomes [39] and grown on microscope
slides. 6 days after electroporation cells were fixed and
IF analysis followed by FISH was performed as described
by Reinson et al. [25]. IF was performed with primary
antibody anti-DAXX (D7810; Sigma-Aldrich) 1:100 and
secondary antibody Alexa Fluor 568 Goat Anti-Rabbit
IgG (A-11004; Invitrogen) 1:1000; HPV DNA was detected
with HPV18 specific probe. Cells were placed under cover-
slips with SlowFade® Gold antifade reagent with DAPI (Invi-
trogen) and analysis was performed with Zeiss confocal
microscope LSM710 using 63x oil-immersion objective.
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